Clinical Trials Browser

monalizumab × Tumor-Agnostic × 1 year × Clear all

NCT06152523 2026-04-06

MONAMI

Phase 2 Withdrawn

Neoplasms

NCT02671435 2025-07-22

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Phase 1/2 Active not recruiting

383 enrolled 48 charts

Neoplasm Metastasis